Induction immunochemotherapy followed by definitive radiotherapy in patients with limited-stage small cell lung cancer: a multicenter study
Year: 2026
Type: article
Abstract: The standard treatment for limited-stage small cell lung cancer (LS-SCLC) is systemic chemotherapy with concurrent or sequential radiotherapy[1][1]. The recent ADRIATIC trial demonstrated that durvalumab, as a consolidation therapy, could significantly improve the overall survival \[OS\] ( P = 0.01
Source: Cancer Biology and Medicine
Language: English
Topic: Lung Cancer Research Studies
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $1,500
OpenAlex ID: W7160953151
FWCI:
Cites:
Cited by:
Related to: